Mammalian cochlear hair cells (HCs) are essential for hearing, and their maturation and function depend on precise regulation of gene expression and chromatin state. NSD2 is a histone methyltransferase that catalyzes dimethylation of histone H3 at lysine 36 (H3K36me2). The role of NSD2 and H3K36me2 in cochlear HC maturation and function was previously unclear. The authors aimed to determine whether and how NSD2 contributes to HC structural integrity and hearing by examining the consequences of HC-specific loss of NSD2.
The investigators generated a cochlear HC-specific Nsd2 knockout mouse to study the cell-autonomous effects of NSD2 deficiency in HCs. They applied integrated multi-omics profiling—including epigenetic, chromatin accessibility, and transcriptomic analyses—to characterize molecular consequences of NSD2 loss. Structural examination of stereociliary bundles and auditory functional testing were used to assess phenotype. The source reports that the model and profiling identified links between NSD2, H3K36me2, chromatin accessibility, gene expression, and phenotype.
HC-specific deletion of Nsd2 produced severe structural defects in stereociliary bundles. These structural abnormalities were accompanied by profound hearing impairment in the knockout mice. The source emphasizes the severity of stereociliary disorganization and the impact on hearing function as primary phenotypes resulting from NSD2 deficiency.
Integrated multi-omics profiling showed that NSD2 deficiency leads to decreased levels of H3K36me2 in cochlear hair cells. The reduction in this histone mark was linked to widespread changes in chromatin accessibility across the genome. According to the source, altered chromatin accessibility correlated with changes in transcriptional programs, indicating that loss of NSD2 reconfigures the epigenetic landscape of HCs.
At the transcriptional level, NSD2 loss triggered aberrant upregulation of genes encoding components of the extracellular matrix (ECM). The source reports a clear association between decreased H3K36me2, remodeled chromatin accessibility, and increased expression of ECM-related genes in the NSD2-deficient HCs.
Transcriptional upregulation of ECM genes translated into excessive accumulation of ECM proteins, including increased collagen deposition, which compromised cochlear tissue structure. The authors link this ECM overaccumulation to the observed stereociliary and tissue abnormalities, proposing that dysregulated ECM homeostasis is a proximate cause of structural disruption in the NSD2-deficient cochlea.
The source reports that intervention targeting the ECM mitigated hearing damage associated with NSD2 deficiency. While the study states that ECM intervention improved outcomes, specific details about the intervention strategy, agent(s), dosing, timing, or the magnitude of improvement were not reported in the source document.
The authors propose an epigenetic mechanism in which NSD2 maintains HC maturation and structural integrity by catalyzing H3K36me2, thereby limiting chromatin remodeling that would otherwise activate ECM gene expression. Loss of NSD2 lowers H3K36me2, increases chromatin accessibility at ECM-related loci, elevates ECM transcription, and leads to excessive collagen accumulation and tissue disruption, culminating in stereociliary defects and hearing loss. Based on these findings, the study suggests a potential therapeutic direction for hearing impairment centered on preventing or reversing ECM accumulation in the cochlea.
This article is a preprint and has not been certified by peer review. The source does not report certain experimental specifics in the summary provided here, including detailed descriptions of the ECM-targeted intervention (agents, administration, and quantitative effect size), full datasets and statistical metrics, or extensive mechanistic validation beyond the multi-omics correlations. Details such as age of mice at assessment, sample sizes, and additional controls are not included in the sections of the source text summarized here.
HC-specific NSD2 deficiency disrupts the epigenetic landscape of cochlear hair cells by reducing H3K36me2, altering chromatin accessibility, and driving transcriptional upregulation of ECM genes. This cascade leads to excessive collagen accumulation, structural compromise of stereociliary bundles, and profound hearing impairment in the knockout model. ECM-targeted intervention was reported to mitigate hearing damage, supporting a causal role for ECM accumulation and identifying ECM modulation as a potential therapeutic avenue. Further peer-reviewed validation and detailed methodological disclosure are required to evaluate translational potential.